Agios Pharmaceuticals (AGIO) Tax Provisions (2012 - 2025)
Agios Pharmaceuticals (AGIO) posted Tax Provisions of -$1.0 million for Q4 2025, up 88.55% on a QoQ basis from -$8.9 million in Q4 2024, and up 88.55% year-over-year from -$538839.4 in Q4 2024.
Agios Pharmaceuticals (AGIO) Tax Provisions (2012 - 2025) Analysis & Trends
Agios Pharmaceuticals' Tax Provisions history runs 5 years deep, the most recent figure standing at -$1.0 million for Q4 2025.
- Quarterly Tax Provisions rose 88.55% year-over-year to -$1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $43.2 million (down 2.3% YoY) and the FY2025 annual result came in at -$1.0 million, down 102.3% from the prior year.
- Tax Provisions was -$1.0 million for Q4 2025 at Agios Pharmaceuticals, up from -$8.9 million in the prior quarter.
- Across five years, Tax Provisions topped out at $53.1 million in Q3 2024 and bottomed at -$8.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2024 | -8.88 Mn |
| Sep 30, 2024 | 53.12 Mn |
| Dec 31, 2014 | 22,000.00 |
| Sep 30, 2014 | -448,000.00 |
| Dec 31, 2013 | -3.67 Mn |
| Sep 30, 2013 | 121,000.00 |
| Jun 30, 2013 | 99,000.00 |
| Mar 31, 2013 | 190,000.00 |
| Dec 31, 2012 | -7.88 Mn |
| Sep 30, 2012 | -452,000.00 |
| Jun 30, 2012 | -588,000.00 |